Acorda Therapeutics Buy Hold or Sell Recommendation
| ACORDelisted Stock | USD 16.20 0.40 2.41% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Acorda Therapeutics is 'Not Rated'. A buy or sell recommendation provided by Macroaxis is an automated analysis based on historical performance and your stated risk tolerance. It serves as guidance on whether to purchase or sell Acorda Therapeutics within the specified time frame.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. Note, we conduct extensive research on individual companies such as Acorda and provide practical buy, sell, or hold advice based on investors' constraints. Acorda Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
Acorda |
Execute Acorda Therapeutics Buy or Sell Advice
The Acorda recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Acorda Therapeutics. Macroaxis does not own or have any residual interests in Acorda Therapeutics or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Acorda Therapeutics' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
Acorda Therapeutics Trading Alerts and Improvement Suggestions
| Acorda Therapeutics is not yet fully synchronised with the market data | |
| Acorda Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 117.63 M. Net Loss for the year was (252.85 M) with profit before overhead, payroll, taxes, and interest of 82.43 M. | |
| Acorda Therapeutics currently holds about 20.7 M in cash with (13.98 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.85. |
Acorda Therapeutics Returns Distribution Density
The distribution of Acorda Therapeutics' historical returns is an attempt to chart the uncertainty of Acorda Therapeutics' future price movements. The chart of the probability distribution of Acorda Therapeutics daily returns describes the distribution of returns around its average expected value. We use Acorda Therapeutics price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Acorda Therapeutics returns is essential to provide solid investment advice for Acorda Therapeutics.
| Mean Return | 1.12 | Value At Risk | -9.57 | Potential Upside | 14.01 | Standard Deviation | 11.54 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Acorda Therapeutics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Note: Acquisition by Jensen Peder of 15000 shares of Acorda Therapeutics at 0.8512 subject to Rule 16b-3 [view details]
Acorda Therapeutics Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Acorda . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Acorda Therapeutics Buy or Sell Advice
When is the right time to buy or sell Acorda Therapeutics? Buying financial instruments such as Acorda Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Acorda Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Small Cap ETFs Thematic Idea Now
Small Cap ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Small Cap ETFs theme has 168 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Small Cap ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Other Consideration for investing in Acorda Stock
If you are still planning to invest in Acorda Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Acorda Therapeutics' history and understand the potential risks before investing.
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |